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Introduction
COVID-19 is a respiratory disease caused by a novel coronavirus 
(SARS-CoV-2) and causes substantial morbidity and mortality. At 
the time of writing, there are no vaccines to prevent COVID-19 
or infection with SARS-CoV-2 or therapeutic agents to treat 
COVID-19. Outbreak forecasting and mathematical modelling 
suggest that case numbers will continue to rise1.
Managing the COVID-19 pandemic poses a considerable 
challenge for global and public health actors. Responding 
institutions and organizations have to utilise non-pharmaceutical 
interventions such as quarantine, self-isolation, social distancing, 
travel restrictions and other public health measures2.
In the current situation of expanding transmission and uncertainty, 
it is important to have evidence to inform such public health 
interventions to ensure maximum public acceptance, success, 
and minimum disruption to the lives of those affected. It is also 
necessary to understand how people acquire, interpret and 
act upon diverse information about COVID-19. This will help 
public health authorities with approaches to communication, and 
choice of communication channels and messaging.
Vaccines and drugs for the treatment and prevention of COVID-19 
require robust evidence generated from clinical trials before they 
can be used. Decisions on how to apply non-pharmaceutical 
interventions such as quarantine, self-isolation, social distancing 
and travel restrictions should also be based on evidence. There 
are some experiential and mathematical modelling data for 
these interventions3,4, but there is a lack of data on the social, 
ethical and behavioural aspects of these interventions in the 
literature5,6.
Therefore, our study aims to produce evidence to inform 
(non-pharmaceutical) interventions such as communications, 
quarantine, self-isolation, social distancing, travel restrictions 
and other public health measures for the COVID-19 pandemic. 
We propose to conduct a mixture of quantitative surveys and 
qualitative interviews to answer our research questions.
Description and rationale of study sites
At the time of writing, governments in Italy, UK, Malaysia 
and Thailand have initiated strict public health measures and 
varying degrees of “lockdowns” to curb the pandemic.
Italy has recorded one of the highest number of COVID-19 
cases in the world and has been restricting the movements of its 
residents since 9 March 2020. On 22 March, the Italian govern-
ment ordered the shutdown of all non-necessary activities and 
movement between cities. In the United Kingdom, as of 23 March 
2020, people have been requested to stay at home except to 
shop for basic necessities, attend to medical needs, travel to and 
from work (if they cannot work from home) and exercise once a 
day.
Malaysia and Thailand have recorded some of the highest 
numbers of COVID-19 cases in Southeast Asia. The Malaysian 
government declared a “Movement Control Order” on 16 
March 2020 which prohibits mass movements and gather-
ing, closure of non-essential businesses and closing its borders. 
On 25 March 2020, the Thai Prime Minister declared a state of 
emergency in Thailand.
It is anticipated that these public health measures will continue 
in some countries (e.g. Italy, Malaysia) or be tightened further 
in other countries (e.g. Thailand, UK) to control the spread of 
the disease in the coming weeks and months. The data generated 
from our study could inform these strategies in real time.
Master protocol
Overarching objective
To produce evidence to inform (non-pharmaceutical) inter-
ventions such as communications, quarantine, self-isolation, 
travel restrictions and other public health measures for the 
COVID-19 epidemic.
Specific objectives
1. To understand the factors that impede and facilitate the 
compliance of quarantine, self-isolation, social distancing 
and travel restrictions at different phases of the epidemic;
2. To explore people’s understanding about quarantine, 
self-isolation, social distancing and travel restrictions;
3. To identify information sources and investigate any rumours/ 
misinformation and to reverse and correct any rumours/ 
misinformation about COVID-19
Research questions
1. What are the perceptions and experiences regarding quarantine, 
self-isolation, social distancing, and travel restrictions?
2. What are the economic, social and ethical impacts (e.g. lost 
wages, challenges in child care, food and household supplies, 
loneliness) of quarantine, self-isolation, social distancing, and 
travel restrictions?
3. How do people understand and define these terms (quarantine, 
self-isolation, social distancing and travel restrictions)? What 
are the barriers and enablers for complying with these measures? 
How do people cope?
4. What are individuals from various communities (e.g. parents, 
caretakers, people from different occupations) most fearful 
of (e.g. loss of wages, dying, spreading to others; being 
unable to care for children/older people/other family members; 
self-isolation; being unable to get care)?
5. What are the rumours circulating in social media, conversations 
and discussions? To what extent has public information been 
clear? How do people obtain information?
Project timeline
The duration of data collection is three months. It is expected 
that the primary analyses will be completed by December 2020. 
The secondary, more in-depth analyses will take another year.
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Study design
We will conduct a mixed methods study using quantitative sur-
veys and qualitative interviews to obtain contextual information 
from communities on the following four themes:
(1) Quarantine and self-isolation
(2) Social distancing and travel restrictions
(3) Wellbeing and mental health
(4) Information, misinformation and rumours
Study sites
The study will be conducted in the UK, Italy, Malaysia 
and Thailand. In light of limitations of travel and holding 
in-person meetings, we will use online/remote methods for 
collecting data.
Study participants
The study participant will be adults who have provided informed 
consent.
Inclusion criteria:
• Adults (age may vary by country)
• Residing in Thailand, Italy, Malaysia or the UK
• Provided consent to participate in the study
• Able to use a computer or smart phone
Exclusion Criterion:
• Individuals who are illiterate (because the data collection 
is online and the survey is self- administered)
Note: Individuals who are tested positive for coronavirus will 
not be excluded unless they meet the exclusion criterion
Study procedures
Recruitment:
Invitation to join the survey will be sent through professional and 
personal contacts via email, other online media, and recruitment 
posters.
There will be two ways of recruiting people to participate in 
the qualitative interviews:
1) Via quantitative survey – at the end of the online survey, par-
ticipants will be asked if they wish to take part in the qualita-
tive research. They will be asked to click on a link that will take 
them to a different webpage that will enable them to provide 
their email address if they are interested to participant in the 
qualitative interview. The email address will not be linked 
to the survey answers. The study team will email the people 
who provided their email address to seek invite them to join 
the qualitative interview.
2) Via recruitment posters advertised on partner websites and 
social media. Interested participants can contact the study team 
directly. The study team will email the people who provided 
their email address to join the qualitative interview.
Participants in the qualitative study will be selected with the aim 
to recruit a maximum variation sample, based on characteris-
tics including participant age, gender, risk and socio-economic 
status.
Informed consent:
In light of the limitations of holding in-person meetings, par-
ticipants will be asked to provide consent online. Consent will be 
taken separately for participation in the quantitative survey and 
the qualitative interviews.
Data collection methods, study participants, sample size and 
topics for discussion
We will conduct the following:
Quantitative method: About 600 online surveys per country. 
No formal sample size calculation has been performed. This 
number is more than what is recommended for a mixed meth-
ods study7. Furthermore, it is feasible for data collection within 
three months. Surveys will be self-administered. The online 
survey will be available in English, Thai and Italian (see 
extended data8).
Qualitative method: Online (via MS Teams, telephone, or other 
approved platforms) interviews and focus group discussions with 
25–35 participants per country. Actual numbers will depend on 
context, changes in epidemic, and data saturation. Qualitative 
data collection will be conducted by in-country interviewers 
in the language (English, Malay, Thai or Italian) preferred 
by the participant. A pre-prepared topic guide will be used to 
direct conversations (extended data9).
Questions for both quantitative and qualitative will be guided 
by the following themes:
(1) Quarantine and self-isolation
(2) Social distancing and travel restrictions
(3) Wellbeing and mental health
(4) Information, misinformation and rumours
We will target different communities (based on age, gender, risk 
and socio-economic status) within Thailand, Italy, Malaysia 
and the UK. Potential communities include those working in the 
healthcare sector, tourism industry, taxi drivers, market vendors, 
university students and public advisory groups.
Data analysis and management
Quantitative data: Quantitative survey data will be entered and 
analysed using SPSS software. Data may also be analysed using 
Stata 15.0 (or later) software. The quantitative data will be retrieved 
from the online survey platform. The data can be accessed real 
time to monitor the response rate to boost the sharing of the 
link to reach the target sample size. Once the data have been 
collected we will review the data and bring together the related 
responses. Frequency counts and percentages will be used to 
summarise categorical data. Associations between categorical 
variables will be assessed using the Pearson Chi-Square tests 
or Fisher’s exact tests as appropriate. Data will be presented in 
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different tables, graphical displays and summary statistics. Fur-
ther analysis to investigate the relationship between differ-
ent variables will be performed. Tests of significance will be 
performed at 5% significance level.
Qualitative data: Interviews and focus group discussions will 
be audio recorded where possible10. They will be transcribed, 
cleaned and translated to English where necessary and appro-
priate, and exported into NVivo (© QSR International Pty Ltd) 
or equivalent software that will be used to manage the data. In 
all other cases, detailed written notes taken immediately after 
each interview will serve as the data for analysis10. Audio files 
will be kept in country until they have been transcribed and 
interview transcripts will be kept securely. All audio files will 
be destroyed once all transcripts have been completed and 
verified. Codes will be established for each participant to enable 
appropriate collation of data sets, themes and sub-themes for 
qualitative analysis. Qualitative data analysis will be based on 
thematic content analysis. Initial themes and categories will be 
developed iteratively through successive coding of the raw data 
transcripts, and informed by the research objectives, issues 
emerging from the raw data and media. To support the validity 
and trustworthiness of data analysis, two researchers will 
independently develop their own coding categories, followed by 
a discussion of similarities and differences. Where information 
gathered by different methodologies is contradictory rather than 
complementary, divergences will be outlined and discussed in 
reports and publications.
Qualitative and quantitative data will be analysed by country 
and pooled for comparison between countries.
Direct access will be granted to authorised representatives 
from the sponsor, ethics committees, and regulatory authorities 
to ensure compliance with regulations.
De-identified data will be stored digitally and indefinitely. 
De-identified data may also be shared with other research groups. 
All applications for data sharing will be reviewed by the MORU 
Data Access Committee in consultation with country Principal 
Investigators. All researchers accessing the data need to adhere to 
a set of terms and conditions that aim to protect the interests of 
research participants and other relevant stakeholders.
Data generated from this study will adhere to the 2016 “Statement 
on data sharing in public health emergencies”.
Quality control and quality assurance procedures
The study will adhere to the relevant guidelines for surveys and 
qualitative research. All interviewers, and transcribers will be 
trained prior to the study.
The study will be conducted in accordance with relevant 
national and international guidance and regulations.
Survey questions have been pilot-tested and have undergone 
pilot testing in accordance with established cognitive interviewing 
and questionnaire design methodology11.
Discontinuation/withdrawal of participants from study
Each participant has the right to withdraw from the study at any 
time. Withdrawal of consent to participate from this study will 
result in exclusion of the data for that participant from analysis. 
Withdrawn participants will not be replaced. If identified, the 
reason for withdrawal will be recorded.
In addition, investigators may discontinue participation of any 
individual from this study at any time if the investigator considers 
it necessary for any reason.
Audio recordings will be deleted if a participant decides to 
withdraw mid-interview. For those participating in a focus group 
discussion, if a participant withdraws mid-focus group, those 
portions of the audio recording that capture their views will be 
deleted.
Ethical and regulatory considerations
Risk and harm:
This is a minimal risk study posing minimal risk and harm to the 
participants.
The main ethical issues in this study relate to privacy and 
confidentiality. Care will be taken to maintain privacy during 
the audio recording of interviews and interactions with individual 
participants.
Approvals:
The protocol, informed consent form, participant information 
sheet and any associated materials have been approved by the 
following ethics committees:
Oxford Tropical Research Ethics Committee (OxTREC, 
520-20); University Tunku Abdul Rahman Scientific and 
Ethical Review Committee (U/SERC/63/2020); Ministry of 
Health Malaysia Medical Research and Ethics Committee 
(NMRR-20-595-54437-IIR) and the Ethics Committee of the 
Faculty of Tropical Medicine, Mahidol University (MUTM 
2020-031-01). Ethics committee approval is not required for the 
study to be conducted in Italy as OxTREC covers it.
The Chief and country Principal Investigators will submit and, 
where necessary, obtain approval from the above parties for 
all amendments to the original approved documents.
Participant confidentiality:
The study team members will ensure that the participants’ 
confidentiality is maintained. The participants will be identified 
only by a participant identification number on all study documents 
and any electronic database. All documents will be stored 
securely and only accessible by study staff and authorised 
personnel. The study will comply with the EU General Data 
Protection Regulation (GDPR) and country specific data protection 
regulations.
Compensation:
Participants will not be offered any payment to complete the 
online survey. Participants who take part in the interviews and 
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focus groups will be compensated in kind according to country 
guidelines for their time.
Benefits: 
There will be no immediate benefits for any of the study 
participants. The chief benefit to participation in this study is 
that participants will be afforded the opportunity to contribute 
to the generation of new knowledge. 
Public engagement and involvement:
As part of the development of our study and data collection 
tools, we have conducted a series of public engagement or public 
involvement activities e.g. with the existing community advisory 
boards12,13 and Bangkok Health Research Interest Group. We 
believe that public engagement and involvement is necessary for 
ethical research14. The INVOLVE group, the UK’s national 
advisory group for public involvement defines public involvement 
as research that is actively carried out ‘with’ or ‘by’ members 
of the public rather than ‘to’, ‘about’, or ‘for’ them.
Reporting:
The country Principal Investigators shall submit progress reports 
and end-of-study reports to the relevant ethics committees.
Publication policy
The Chief Investigator will lead writing and reviewing of drafts 
of the manuscripts, abstracts and any other publications arising 
from the overall study. The country Principal Investigators 
will lead the writing of country publications in collaboration 
with the Chief Investigator. Authorship will be based on the set 
of criteria outlined by the International Committee of Medical 
Journal Ethics. The study results will also be published as 
regular short reports, and an evaluation report of the online data 
collection approach.
Dissemination of information
Regular short reports will be made available in real time to 
public health authorities and researchers, including:
• WHO COVID-19 Research Roadmap Social Science 
Research Working Group (the Chief Investigator, PYC 
is a member of the group)
• UK Emergency Preparedness and Response Health 
Protection Research Unit
• Health professionals and healthcare staff from the 
Department of Disease Control, Thailand Ministry of 
Public Health, e.g. Division of Communicable Diseases, 
Bureau of Epidemiology, Health Intervention and 
Technology Assessment Program (HITAP)
• Italian Ministry of Health
• Italian Ministry of Innovation Technologies and 
Digitalisation
• Ministry of Health, Malaysia
• Network of research ethics committees in participating 
countries
• Research networks for pandemics and infectious 
diseases e.g. SoNAR-Global Network, Public Health 
Emergency Preparedness and Response Ethics Network 
(PHEPREN)
• University researchers and other organisations working 
on COVID-19 response
Results of the will be published as academic publications and 
presented at academic conferences. They will also be available 
in lay language for dissemination to the wider public.
Details of the study are available from the study website: 
https://www.tropmedres.ac/covid-19/sebcov
Study status




No data are associated with this article
Extended data
Zenodo: Online survey questions: Social, ethical and behavioural 
aspects of COVID-19. http://doi.org/10.5281/zenodo.37649138 
This project contain the following extended data:
- SEBCOV_Survey_AllVersions_V1.0_24Apr2020.pdf 
(Study survey questions in English, Thai and Italian)
Zenodo: Topic guide for qualitative study: Social, ethical and 
behavioural aspects of COVID-19. http://doi.org/10.5281/ 
zenodo.37779349 
This project contains the following extended data:
- SEBCOVTopicGuide_30April2020.pdf (Topic guide for 
qualitative study)
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
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